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Abstract –
The aim of this work is to clarify the incidence of
meningitis/encephalitis in SARS-CoV-2 patients.
We conducted an initial search in PubMed using the
Medical
Subject
Headings
(MeSH)
terms “meningitis,” and “encephalitis,”, and
“COVID-19” to affirm the need for a review on the
topic
of
the
relationship
between
meningitis/encephalitis and SARS-CoV-2 infection.
We included case series, case reports and review
articles of COVID-19 patients with these
neurological symptoms.
Through PubMed database we identified 110
records. After removal of duplicates , we screened 70
record, and 43 were excluded because they focused
on
different
SARS-CoV-2
neurological
complications. For eligibility, we assessed 27 fulltext articles which met inclusion criteria. Seven
articles were excluded, and twenty studies were
included in the narrative review, in which
encephalitis and/or meningitis case reports/case
series were reported.
Neurological manifestations of COVID-19 are not
rare,
especially
meningoencephalitis;
the
hypoxic/metabolic changes produced by the
inflammatory response against the virus cytokine
storm can lead to encephalopathy, and the presence
of comorbidities and other neurological diseases,
such as Alzheimer’s disease, predispose to these
metabolic changes. Further study are needed to
investigate
the
biological
mechanisms
of
neurological complications of COVID-19.
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I. INTRODUCTION
The Severe Acute Respiratory Syndrome-CoronaVirus-2
(SARS-CoV-2) was firstly and officially identified on
January 2020 in Wuhan, China, from a patient with
atypical pneumonia1; the COVID-19 global pandemic was

declared two months later, affecting millions of people
and engaged clinicians around the world in an
unprecedented effort to limit the viral spread and treat
affected patients2. As of August 18, 2020, the COVID-19
pandemic has resulted in more than 22 million confirmed
cases worldwide and more than 780.000 deaths.
SARS-CoV-2 primarily affects the respiratory tract; the
most common clinical symptoms are fatigue, cough,
shortness of breath, and mainly respiratory tract
symptoms3.
Coronaviruses are respiratory viruses with neurotropic
capacities, which allow them to avoid the immune
response; viral RNA has been found in the cerebrospinal
fluid, after SARS-CoV exposure, in patients with
encephalitis, ischemic stroke and polyneuropathy4-6.
Neurological SARS-CoV-2 virus-associated symptoms
are not uncommon, and an increasing number of cases
have presented with neurologic manifestations (such as
headache, anosmia, taste disorders, Guillan-Barrè
syndrome, and meningoencephalitis) and can be
devastating complications7,8; the common neurological
symptoms included olfactory (60.6%) and gustatory
(61%) disorders, especially in mild cases9. In one of most
representative case series from Wuhan, China, 36.4% of
patients had neurological complications10.
The pathophysiological mechanisms have not been
completely established, but the hypoxic/metabolic
changes, produced by the inflammatory response against
the virus cytokine storm, can lead to encephalopathy11-12.
The SARS-CoV-2 infection involves the central nervous
system due to the direct neuroinvasion and, mainly, the
neurological sequelae due to the systemic innate-mediated
hyper-inflammation.
The
possible
routes
of
neuroinvasiveness of SARS-CoV-2 are well summarized
by Khan and Gomes13; the hematogenous route, through
which the virus infects endothelial cells of the blood-brain
barrier and invades neuronal tissue, and the neuronal
retrograde spread, via olfactory nerves from the nasal
cavity through cribriform plate, the virus reaching the
central nervous systems, are the most accepted theories14.
Besides, a recent theory suggested that neuroinvasion via
the enteric pathway can be possible, due to the enteric
nervous system invasion or reaching the central nervous
system via intestinal vagal afferents15.
Low levels of Angiotensin-converting enzyme 2 (ACE2),
a functional receptor for the SARS-CoV-2, has been
detected in the human brain16; moreover, a recent study
demonstrated that the brain is the principal target organ
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for SARS-CoV in transgenic mice for human ACE2
receptor17.
Moreover, a potential role of the spike glycoprotein (S1)S1 IgG antibody complex was hypotized to facilitate the
entry of the virus into the host immune cells18.
The purpose of this brief review is to clarify the incidence
of meningitis/encephalitis SARS-CoV-2 associated.
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Several cases of meningoencephalitis have been reported
since February 2020, as shown in Tab. 1.

Table
1.
Clinical
characteristics
meningoencephalitis case-report

of

II. METHODOLOGY
2.1 Search Strategy and Study Selection
We conducted an initial search in PubMed using the
Medical Subject Headings (MeSH) terms
“meningitis,” and “encephalitis,”, and “COVID-19” to
affirm the need for a review on the topic of the
relationship between meningitis/encephalitis and SARSCoV-2 infection.
The research protocol was designed to define the objective
and the methodology of the study; the protocol was
neither registered nor published.
The search strategy was chosen in consultation with a
senior librarian at the University of Salerno (Salerno,
Italy). A comprehensive review of the English-language
literature was performed by using the following databases:
the National Library of Medicine’s version of PubMed
(1988 to June 2020). The last search was performed on
August 16, 2020.
We included case series, case reports and review articles
of COVID-19 patients affected by neurological symptoms.
After exclusion of duplicates, all articles were evaluated
through title and abstract screening by two independent
reviewers (Pietro De Luca and Giorgio Iaconetta). The
same two reviewers performed an accurate reading of all
full-text articles assessed for eligibility, and performed a
collection of data to minimize the risk of bias.
Inconsistencies regarding inclusion of a given study were
adjudicated by a third reviewer (Ettore Cassandro).
III. RESULTS
Through PubMed database we identified 110 records.
After removal of duplicates , we screened 70 record, and
43 were excluded because they focused on different
SARS-CoV-2 neurological complications. For eligibility,
we assessed 27 full-text articles which met inclusion
criteria. Seven articles were excluded for the following
reasons: a) Articles in Polish (n= 1), b) Article in Chinese
(n= 6). Twenty studies were included in the narrative
review, in which encephalitis and/or meningitis case
reports/case series were reported.
IV. DISCUSSION
The SARS-CoV-2 infection is not only a respiratory
disease; neurological involvement is not rare. This has
been clear from the first analysis of 214 cases of COVID19 in Wuhan (China), where 36.4% (78) patients
presented with neurological complications19.
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Author, Country

Number of meningoencephalitis
observed

Clinical presentation

Efe et al, Germany

1

A 35-year-old woman with headache and seizure. The MRI
No postoperative deficits, and her symptoms
was suggestive of high-grade glioma. A left anterior temporal completely improved
lobe was performed. histologic examination revealed
encephalitis

Abdi et al, Iran

1

A 58-year-old woman presented with decreased level of
consciousness and the inability to walk. Brain MRI indicated
differ confluent white matter hyperintensity on FLAIRweighted-MRI at the left side

After 10 days, status epileptics developed and
the patient died one day later

Bernard-Valnet et al,
Switzerland

2

1.

1.

2.

A 64-year-old woman presented a tonico-clonic
seizure; MRI was normal, but lumbar puncture was
compatible with viral meningoencephalitis and SARSCoV-2 was detected in her nasopharyngeal swab
A 67-year-old woman, already diagnosed with SARSCoV-2 infection for 17 days with mild respiratory
symptoms, presented an intense wake-up headache,
bilateral grasping, aggressiveness and left hemianopia
and sensory hemineglect.

Outcome

2.

The patient markedly improved 96 h after
admission with resolution of her
symptoms
Neurological symptoms resolved within
24 h, except for a mild headache. The
patient was discharged 72 h after
admission with no symptoms

McAbee et al, United
States

1

A 11-year-old child presented with status epileptics; he had a
two-day history of generalized weakness without respiratory
symptoms. Electroencephalography revealed frontal
intermittent delta activity.

Recovery without treatment was complete in six
days

Ye et al, China

1

A Wuhan male, who previously had fever, shortness of
breath and myalgia, presented with his consciousness
progressed to confusion. Meningeal irritation signs and
extensor plantar response were present.

The patient was discharged 17 days after
admission

El Otmani et al, Morocco

1

69-yr-old man with a 7-day history of fever and cough, was
admitted for confusion and severe headache; brain MRI was
normal.

At discharged on day 10, mild neuropsychiatric
features were still present with an alteration of
executive functions
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The first case of encephalitis with SARS-CoV-2 isolated
in cerebrospinal fluid was reported by Moriguchi and
colleagues on February 2020; this was the case of a 24year-old man who was found lying on the floor with
consciousness disturbance (GCS 6) nine days after he felt
headache and generalised fatigue. This was the first case
report in which the Authors highlighted the possibility of a
neuroinvasive potential of COVID-1920.
Bernard-Valnet et al. reported the clinical evolution of two
patients, a 64-year-old woman and a 67 year-old man,
who developed meningoencephalitis after several days of
mild respiratory symptoms; both patients showed a
significant improvement 24 hours after admission21.
A combination of altered consciousness, focal
neurological defects, fever, and cerebrospinal fluid
abnormalities in a 69-year-old man one week after the
onset of COVID-19 was described by El Otmani et al 22.
They reported that the detection of SARS-CoV-2 in
bronchoalveolar lavage as the time of lumbar puncture
was in favour of a direct infection mechanism.
In addition, Pilotto et al23 described the case of a 64-yearold man with a mild respiratory impairment who
developed a kinetic mutism due to an encephalitis that
highly improved after an high-dose steroid treatment. A
case of SARS-CoV-2 infection who presented with
isolated encephalitis was reported by Ye et al24.
Moreover, the first pediatric case was described by
McAbee et al25, after two days of generalized weakness,
without respiratory symptoms, he presented with epileptic
seizures requiring four anticonvulsant medications.
Also atypical presentations of neurological involvement
are reported. A COVID-19 associated encephalitis
mimicking glial tumor was described by Efe et al.; the
Authors suggested that severe neurologic manifestations
of COVID-19 could mimic this brain tumors26. A mild
encephalitis, in a 75-year-old man with a history of mild
Alzheimer’s disease, was observed with a reversible
splenial lesion27. A unique case of neurological symptoms
developed before clinical and pulmonary manifestations,
has been described by Abdi et al28.
Kremer et al retrospectively reviewed the characteristics
of 64 confirmed COVID-19 patients with neurological
complications, who underwent a brain MRI; encephalitis
was one of the most common neuroimaging finding
(17%); moreover, patients with encephalitis were younger.
In this work, the Authors were incline to accept the
autoimmune/inflammatory theory, due to the absence of
the virus in cerebrospinal fluid and the presence of signs
of inflammation in both neuroimaging and cerebrospinal
fluid29. We found 4 systematic review aiming to
investigate the evidence of neurological impairment in
COVID-19. Ghannam et al. reported that 19 patients
(23%) had encephalitis or encephalopathy30; on the
contrary, Tsai et al. reviewed only 4 case reports about
meningoencephalitis in COVID-19 patients31.
Romoli et al. reported a similar rate, and they suggested to
perform, in case of suspected neuroinvasion, PCR testing
for SARS-CoV-2 in cerebrospinal fluid and anti-SARSCoV-2 IgM-IgG testing in serum, and cerebrospinal fluid
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to check for intrathecal humoral immune reaction32.
Moreover, recently the presence of SARS-CoV-2 RNA in
the cerebrospinal fluid has been detected by genome
sequencing in a patient with clinically proved
meningoencephalitis in Japan33.
The direct invasion, via hematogenous pathways, is
considered by Wang et al. to be responsible for the rapid
progression of neurological symptoms in patients with
encephalitis [6]. In Agarwal et al. opinion’s, the
encephalitis could be due to the direct effect of the virus
on the brain, or secondary to immune-mediated changes as
seen with H1N134.
It is actually unknown if the COVID-19 infection could
per se represent an independent risk factor for the
developing of neurological complications35. Pre-existing
disorders of the central nervous system may play a role in
exacerbating the disease, and may be an important risk
factor for increased pulmonary complications. This
question is supported by Arg et al36, who suggested that
the presence of neurological disease predisposes to
hypoxic/metabolic changes and to encephalopathy; in
addition they found that encephalitis is common in older
patients (>50-year-old), in patients critically ill, and most
of these patients presented lung abnormalities and many
of them were already on mechanical ventilation, or in the
intensive care unit when encephalopathy developed.
Besides, cortical and subcortical T2/FLAIR signal
changes are common neuroimaging abnormalities.
Moreover, several Authors confirmed that, in some cases,
the neurological symptoms can even precede the
respiratory ones or can be the only symptoms in COVID19 patients37.
An earlier recognition of a neurological impairment in
patients with a mild or asymptomatic respiratory infection
can be challenging, also to prevent the long-term
neurological sequelae and to contain social and economic
costs38

V. CONCLUSION
Neurological manifestations of COVID-19 are
not rare, especially meningoencephalitis, which could be a
devastating SARS-CoV-2 associated Central Nervous
System complications, especially in older and critical
patients, in which can cause lifelong disability and death.
The hypoxic/metabolic changes produced by the
inflammatory response against the virus cytokine storm
can lead to encephalopathy, and the presence of
comorbidities and other neurological diseases (as
Alzheimer’s disease) predispose to these metabolic
changes. Also the autoimmune response can play a role in
the pathogenesis of brain damage related to SARS-CoV-2.
Further studies are needed to investigate the biological
mechanisms of neurological complications of COVID-19.
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